BIOMERIEUX
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
16165_1437493_Declaration_Capital_et_droits_de_vote_au_30_09_2026.pdf
Septembre 2026 - Déclaration sur le nombre d\'actions composant le capital social et sur le nombre de droits de vote correspondant
Filed with Euronext ·
6ix hasn’t read this filing yet.
View original source (Euronext)Company analysis
Earlier from Biomerieux Sa
- BioMerieux: BioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
- bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026
- BioMerieux: BioMérieux – First-Half 2026 Results
- bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry